KBLB
Kraig Biocraft Laboratories, Inc.
Key Financials
Net Income
$-3623353
↓ 6.6%
Revenue
$401620
↑ 312.7%
Operating Income
$-3374793
↓ 9.8%
EPS (Diluted)
$0.00
NaN%
Total Assets
$2.6M
↑ 70.4%
Cash & Equivalents
$1.8M
↑ 165.9%
Shareholders' Equity
$-7998958.00
↑ 1.8%
Long-term Debt
$8755.00
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/13/2026 | View on SEC |
| 424B3 | 5/22/2026 | View on SEC |
| 424B3 | 5/22/2026 | View on SEC |
| 424B3 | 5/22/2026 | View on SEC |
| 10-Q | 5/14/2026 | View on SEC |
| 424B3 | 5/14/2026 | View on SEC |
| 424B3 | 5/14/2026 | View on SEC |
| EFFECT | 5/13/2026 | View on SEC |
| POS AM | 5/11/2026 | View on SEC |
| 424B3 | 4/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | KBLB |
| Company Name | Kraig Biocraft Laboratories, Inc. |
| CIK | 1413119 |
| Sector | Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2820 |
| SIC Description | Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | WY |
| Phone | (734) 619-8066 |